Close Menu

immune repertoire sequencing

Researchers used viral repertoire sequencing to characterize an early-stage HIV-neutralizing antibody, an important step toward developing a vaccine.

After scrapping initial plans to develop a diagnostic instrument, the company has been working for several years to advance its single-cell droplet platform for targeted drug development.

An NGS-based assay was better at diagnosing CTCL than PCR-based tests, and could distinguish between malignant and benign skin lesions and identify recurrence.

The technique can help provide a better understanding of transplant tolerance and may have implications for monitoring and predicting rejection.

Immune sequencing will be done in HudsonAlpha's newly established CLIA laboratory.

Adaptive hopes to develop a gold standard for immune sequencing using the combined technologies.

Adaptive Biotechnologies CEO Chad Robins will remain as CEO, and Sequenta CEO Tom Willis and CSO Malek Faham will join the senior leadership team.

Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse.

Researchers used cell sorting and immune sequencing to uncover an unexpected diversity in T cell response to microbes and vaccines.

NEW YORK (GenomeWeb) — A study using next-generation sequencing to measure changes in T-cell receptor genes of patients treated with anti-CTLA-4 drugs like Bristol-Myers Squibb's Yervoy (ipilimumab) has found that patients whose T-cell landscape changed little from a pre-treatment baseline had im

Pages

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.